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The delivery of high-quality evidence-based healthcare strongly depends on the translation of 61 
scientific evidence into clinical practice guidelines (CPGs). Evidence based CPGs can improve practice 62 
in terms of quality and outcomes of healthcare 1 by encouraging interventions of proven benefit and 63 
discouraging ineffective or harmful interventions 2-4. CPGs have also been shown to improve the 64 
consistency of healthcare, promoting homogeneity in levels of care for similar clinical problems 65 
independently of the healthcare professional, institutional setting or country 5. Adherence to 66 
national and international CPGs is suboptimal throughout Europe. Even with the availability of 67 
comprehensive urological CPGs, based on standardised and high-quality methodology, a significant 68 
gap still exists in terms of CPG application in clinical practice 6-8, hampering the delivery of high-69 
quality urological care 9.  70 
The issues which drive non-adherence to urological CPGs are not well understood. The EAU 71 
Guidelines Office “IMAGINE” project (IMpact Assessment of Guidelines Implementation and 72 
Education) has been developed to identify impediments and design solutions. Implementation 73 
science is the appropriate framework to identify the barriers to knowledge transfer, or more 74 
importantly, the optimum interventions to limit or overcome such barriers to improve CPGs 75 
adherence allowing for the optimisation of healthcare resources whilst ultimately improving patient 76 
outcomes 10. In order to design interventions to increase adherence to CPGs, we must first measure 77 
baseline adherence to CPGs across Europe. To effectively measure baseline adherence, IMAGINE has 78 
launched a European wide multi-centre retrospective observational study in collaboration with 79 
European National Urological Societies endorsing the EAU Guidelines. At present, the EAU 80 
Guidelines are endorsed by 86% of European countries, including all 27 EU Member States. Before 81 
an audit of guideline adherence is commenced, all participating National Societies are asked to 82 
complete a brief survey that assesses if they have National Guidelines covering the same 83 
recommendation as the one being audited and if so, to what extent the guidance differs.    84 
IMAGINE reviewed all EAU oncology guidelines for ‘strong’ recommendations with level 1a evidence 85 
(1a: meta-analysis of randomised controlled trials). The group then surveyed oncology panels to 86 
prioritise the identified level 1a recommendations for which there was known/suspected 87 
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heterogeneity in practice and where addressing the heterogeneity would likely have a positive 88 
impact on patient outcomes and/or economic burden. Using this method, the following 89 
recommendation was prioritised for the pilot study: Do not offer neoadjuvant androgen deprivation 90 
therapy (ADT) before surgery in men with locally advanced or high-risk prostate cancer. In this 91 
context, initial studies in Italy have estimated that a quarter of prostate cancer patients received 92 
ADT contradictory to the recommendation of the EAU Prostate Cancer Guidelines, with 93 
approximately 50% receiving ADT prior to surgery 6. Misuse of ADT was associated with increased 94 
costs for the healthcare system and higher rates of avoidable side effects for patients. It is unclear 95 
why ADT is prescribed by some clinicians against the recommendations of the EAU Guidelines 96 
especially given the high certainty of the evidence upon which the current EAU ADT Guidelines 97 
recommendation is based. Whilst informative, the current studies do not give a high enough 98 
resolution of practice across Europe and a more methodologically robust audit is required.  99 
To map ADT practice patterns across Europe, IMAGINE has created a bespoke online data collection 100 
platform. In collaboration with the European National Urological Societies, IMAGINE will identify 8 or 101 
16 sites per country (nations with populations >35 million contributing more sites), covering high 102 
and low volume centres (high volume defined as >50 prostatectomies/year), academic and 103 
community hospitals, and public and private hospitals. Each site will have a nominated site 104 
coordinator who will be responsible for retrospectively auditing 20 (low volume centre) or 40 (high 105 
volume centre) eligible patients using an inbuilt random date generator to identify cases in an 106 
unbiased way. No identifiable personal participant or patient information will be collected, the 107 
hospitals will be reviewing data on their own patients (which they will confirm that they have the 108 
right to do, as secondary medical research, subject to any variations in data privacy law 109 
implemented in their country) and no personal data will be transferred to or processed by IMAGINE, 110 
hence IMAGINE's collation and analysis of the audit results of each site will not include the 111 
processing of personal data and so the General Data Protection Regulation (GDPR) will not apply. 112 
This audit is classified as service evaluation and does not require sponsorship and ethical review.  113 
The audit will provide a robust map of guideline adherence to ADT recommendations in Europe as 114 
well as a validated platform to map adherence to other recommendations. The key to changing non-115 
adherent behaviours is to understand what is initiating and maintaining undesirable behaviours, and 116 
what might facilitate desirable ones 11. The ADT adherence map will inform sampling for the second 117 
phase of the project: a behavioural theory informed investigation into the barriers and facilitators to 118 
adherence to the ADT recommendation. By incorporating content analysis of National and/or local 119 
guidelines, local policies and pathways and semi-structured interviews organised using the 120 
theoretical domains framework (TDF) 11,12 in a sample of European countries, IMAGINE will elucidate 121 
how organisational, social, environmental, and personal factors may influence how healthcare 122 
professionals manage patients in a range of settings. A similar investigation of barriers to ADT de-123 
implementation in the Unites States is underway and we look forward to learning from their results 124 
13. Ultimately, the contextual information gathered in the qualitative studies will inform the 125 
development of targeted interventions tailored to local contexts aiming to improve adherence, this is 126 
critically important as interventions are more effective when designed to address local barriers 14. 127 
Finally IMAGINE will map the findings to the Behaviour Change Taxonomy 15 to enable us to identify 128 
potential behaviour change interventions, which we will aim to test using randomised or controlled 129 
before and after designs.  130 
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Figure 1: IMAGINE framework outlining the movement of recommendations from CPGs to clinical 131 
practice based on the knowledge-to-action framework 16. 132 
 133 
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Uros IMAGINE representative Slovenian Urological Association 
Andraz IMAGINE representative Slovenian Urological Association 
Manuel Esteban 
Fuertes 
President Spanish Association of Urology 
Mario Alvarez-
Maestro 
Director International Relations and IMAGINE representative Spanish Association 
of Urology; Department of Urology, Hospital Universitario La Paz, Madrid, Spain  
Antoni Vilaseca IMAGINE representative Spanish Association of Urology 
Rodrigo García-
Baquero 
IMAGINE representative Spanish Association of Urology; Urology Department, 




President and IMAGINE representative Swedish Urological Association; 
Department of Molecular Medicine and Surgery, Karolinska Institutet, and 
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Department of Pelvic cancer, Karolinska University Hospital, Stockholm, Sweden 
Johan Styrke IMAGINE representative Swedish Urological Association; Kirurgiskt centrum / 
Urologi, Sundvalls sjukhus, 51 86 Sundsvall 
Gezim Galiqi President Albanian Society of Urology 
Bilbil Hoxha IMAGINE representative Albanian Society of Urology 
Evisa Zhapa IMAGINE representative Albanian Society of Urology 
Rezart Xhani IMAGINE representative Albanian Society of Urology; Department of Urology, 
University Hospital Centre “Mother Teresa”, Tirana 1000, Albania. 
Sergey Fanarjyan President Armenian Association of Urology 
Ruben Hovhannisyan Vice-President and IMAGINE representative Armenian Association of Urology; 
Department of Laparoscopic, Oncological and Female Urology and the Centre for 
the Prevention and Treatment of Prostate Cancer "SLAVMED" Medical Centre, 
Armenia 
Avoyan E. Armen IMAGINE representative Armenian Association of Urology; Urology Department 
Medical Centre Astghik, Armenia 
Rafael Badalyan IMAGINE representative Armenian Association of Urology; Urology and Men’s 
Health Service, YSMU, 13, Moskovyan str., 0001 Yerevan, Armenia 
Mustafa Hiroš President and IMAGINE representative Urological Association of Bosnia & 
Herzegovina 
Davor Tomić IMAGINE representative Urological Association of Bosnia & Herzegovina 
Damir Aganović IMAGINE representative Urological Association of Bosnia & Herzegovina 
Archil Chkhotua Secretary General and IMAGINE representative Georgian Urological Association; 
National Center of Urology, Scientific Director, 27 Tsinandali str., 0144 Tbilisi, 
Georgia 
David Nikoleishvili IMAGINE representative Georgian Urological Association 
Zara Tchanturaia IMAGINE representative Georgian Urological Association 
Sigurdur Gudjónsson Secretary General and IMAGIEN representative Icelandic Urological Association; 
Department of Urology, Landspitali University Hospital, Reykjavik, Iceland 
Eirikur Orri 
Gudmundsson 
President Icelandic Urological Association 
Rafn Hilmarsson IMAGINE representative Icelandic Urological Association; Department of Urology, 
Landspitali University Hospital, 101 Reykjavik, Iceland 
Emil Ceban Secretary General and IMAGINE representative Moldovian Society of Urolgy 
Vitalii Ghicavii EAU Liaison and IMAGINE representative Moldovian Society of Urology 
Adrian Tanase President Moldovian Society of Urology 
Vladislav Vasiliev IMAGINE representative Moldovian Society of Urology 
Dragoljub Perovic President Association of Urology of Montenegro 
Marko Vukovic Secretary General Association of Urology of Montenegro; Urology clinic, Clinical 
centre of Montenegro, University of Montenegro. 
Stanisavljevic Rade IMAGINE representative Association of Urology of Montenegro; Urologist. Urology 
clinic, General hospital, Bar, Montenegro 
Nenad Radovic IMAGINE representative Association of Urology of Montenegro; Urology clinic, 
Clinical centre of Montenegro, University of Montenegro 
Emil Nasufovic IMAGINE representative Association of Urology of Montenegro; Urology clinic, 
General hospital Bijelo Polje, Montenegro 
Yuri Alyaev President Russioan Society of Urology 
Igor Korneyev EAU Liaison and IMAGINE representative Russian Society of Urology 
Sergei Kotov IMAGINE representative Russian Society of Urology 
11 
 
Vigen Malkhasyan IMAGINE representative Russian Society of Urology 
Dragoslav Basic President, EAU Liaison and IMAGINE representative Urological Section of the 
Serbian Medical Association; Clinic of Urology, Clinical Center Niš; Faculty of 
Medicine, University of Niš, Niš, Serbia 
Miodrag Aćimović IMAGINE representative Urological Section of the Serbian Medical Association 
Saša Vojinov IMAGINE representative Urological Section of the Serbian Medical Association 
Aleksandar Vuksanovic President and EAU Liaison Urological Association of Serbia; Clinic of 
Urology, Clinical Center of Serbia; School of Medicine, University of Belgrade 
Uroš Bumbaširević IMAGINE representative Urological Association of Serbia; Clinic of Urology, Clinical 
Center of Serbia; School of Medicine, University of Belgrade 
Bojan Čegar IMAGINE representative Urological Association of Serbia; Clinic Centre of Serbia, 
Urology Clinic 
Branko Stanković IMAGINE representative Urological Association of Serbia; Clinic Centre of Serbia, 
Urology Clinic 
Hansjörg Danuser EAU Liaison Swiss Society of Urology 
Tullio Sulser President Swiss Society of Urology 
Valentin Zumstein IMAGINE representative Swiss Society of Urology; Kantonsspital St. Gallen (KSSG), 
Urologie, Rorschacherstrasse 95, 9007 St. Gallen 
Ates Kadioglu Vice-President and EAU Liaison Turkish Urological Association 
Hakan Kilicarslan President Turkish Urological Association 
Nusret Can Cilesiz IMAGINE representative Turkish Urological Association 
Erhan Demirelli IMAGINE representative Turkish Urological Association 
Bülent Önal Director International Relations Society for Urological Surgery Turkey; Istanbul 
University- Cerrahpaşa, Cerrahpaşa School of Medicine 
Aydin Mungan President Society for Urological Surgery Turkey 
Serdar Tekgül IMAGINE representative Society for Urological Surgery Turkey 
Levent Türkeri IMAGINE representative Society for Urological Surgery Turkey; M.A.Aydınlar 
Acıbadem University, Altunizade Hospital, Department of Urology, Istanbul, Turkey 
Adil Esen IMAGINE representative Society for Urological Surgery Turkey 
Oleksandr Shulyak EAU Liaison Ukrainian Urological Association  
Sergiy Vozianov President Ukrainian Urological Association  
Alexandr Shulyak IMAGINE representative Ukrainian Urological Association; Institute of urology 
under NAMS of Ukraine 
Serhii Volkov IMAGINE representative Ukrainian Urological Association; Institute of urology 
under NAMS of Ukraine 
Andrii Nesterchuk IMAGINE representative Ukrainian Urological Association 
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